Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/069532external-prioritypatent/WO2012062698A1/en
Application filed by Boehringer Ingelheim IntfiledCriticalBoehringer Ingelheim Int
Publication of TN2013000187A1publicationCriticalpatent/TN2013000187A1/en
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
TNP2013000187A2011-11-072013-04-29Pharmaceutical composition, methods for treating and uses thereof
TN2013000187A1
(en)
Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient